Ixabepilone

In the US, Ixabepilone (ixabepilone systemic) is a member of the drug class mitotic inhibitors and is used to treat Breast Cancer and Breast Cancer - Metastatic.

US matches:

• Ixabepilone


• Ixabepilone Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01DC04

CAS registry number (Chemical Abstracts Service)

0219989-84-1

Chemical Formula

C27-H42-N2-O5-S

Molecular Weight

506

Therapeutic Category

Antineoplastic antibacterial

Chemical Names

(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methylthiazol-4-yl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecan-5,9-dion (IUPAC)

(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione (WHO)

17-Oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]- (1S,3S,7S,10R,11S,12S,16R)- (USAN)

Foreign Names

• Ixabepilonum (Latin)
• Ixabepilon (German)
• Ixabépilone (French)
• Ixabepilona (Spanish)

Generic Names

• Ixabepilone (OS: USAN, JAN)
• Azaepothiolone B (IS)
• BMS 247550-01 (IS: Bristol-Myers)
• NSC-710428 (IS)

Brand Names

• Ixempra
  Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, United States

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.